Atelvia (Warner Chilcott (US), LLC)


Welcome to the PulseAid listing for the Atelvia drug offered from Warner Chilcott (US), LLC. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Warner Chilcott (US), LLC
NON-PROPRIETARY NAME: risedronate sodium
SUBSTANCE NAME: RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, DELAYED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00


Atelvia HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAtelvia from Warner Chilcott (US), LLC
LABELER NAME: Warner Chilcott (US), LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30.1; 4.9(mg/1; mg/1)
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0430-0979_9fc64dd0-15af-45f8-8fa5-9ac8f37783a4
PRODUCT NDC: 0430-0979
APPLICATION NUMBER: NDA022560

Other RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Risedronate Sodium
Allergan, Inc.Actonel
Warner Chilcott (US), LLCAtelvia